| Year |
Citation |
Score |
| 2023 |
Valencia SM, Rochat E, Harnois MJ, Dennis M, Webster HS, Hora B, Kumar A, Wang HS, Li L, Freed D, Zhang N, An Z, Wang D, Permar SR. Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection. Npj Vaccines. 8: 154. PMID 37816743 DOI: 10.1038/s41541-023-00749-0 |
0.364 |
|
| 2022 |
He L, Taylor S, Costa C, Görzer I, Kalser J, Fu TM, Freed D, Wang D, Cui X, Hertel L, McVoy MA. Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L. Viruses. 14. PMID 35891489 DOI: 10.3390/v14071508 |
0.342 |
|
| 2022 |
Li F, Freed D, Heidecker G, Galli J, Durr E, Wang D. A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments. Vaccine. PMID 35577627 DOI: 10.1016/j.vaccine.2022.04.102 |
0.374 |
|
| 2020 |
Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, Donnell GO, Galli JD, Swoyer R, Touch S, Wen Z, Antonello J, Zhang L, Flynn JA, Cox KS, et al. Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. Npj Vaccines. 5: 16. PMID 33580035 DOI: 10.1038/s41541-020-0163-z |
0.301 |
|
| 2020 |
Su H, Ye X, Freed DC, Li L, Ku Z, Xiong W, Gao P, Liu X, Montgomery D, Xu W, Espeseth AS, Wang D, Ma N, Fu TM, Zhang N, et al. A potent bispecific neutralizing antibody targeting glycoprotein B and the gH/gL/pUL128/130/131 complex of human cytomegalovirus. Antimicrobial Agents and Chemotherapy. PMID 33361306 DOI: 10.1128/AAC.02422-20 |
0.312 |
|
| 2020 |
Jenks JA, Nelson CS, Roark HK, Goodwin ML, Pass RF, Bernstein DI, Walter EB, Edwards KM, Wang D, Fu TM, An Z, Chan C, Permar SR. Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans. Science Translational Medicine. 12. PMID 33148624 DOI: 10.1126/scitranslmed.abb3611 |
0.31 |
|
| 2020 |
Goodwin ML, Webster HS, Wang HY, Jenks JA, Nelson CS, Tu JJ, Mangold JF, Valencia S, Pollara J, Edwards W, McLellan JS, Wrapp D, Fu TM, Zhang N, Freed DC, ... Wang D, et al. Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection. Virology. 548: 182-191. PMID 32838941 DOI: 10.1016/J.Virol.2020.07.009 |
0.405 |
|
| 2020 |
Ye X, Su H, Wrapp D, Freed DC, Li F, Yuan Z, Tang A, Li L, Ku Z, Xiong W, Jaijyan D, Zhu H, Wang D, McLellan JS, Zhang N, et al. Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step. Plos Pathogens. 16: e1008736. PMID 32745149 DOI: 10.1371/Journal.Ppat.1008736 |
0.43 |
|
| 2020 |
Plotkin SA, Wang D, Oualim A, Diamond DJ, Kotton CN, Mossman S, Carfi A, Anderson D, Dormitzer PR. The Status of Vaccine Development Against the Human Cytomegalovirus. The Journal of Infectious Diseases. 221: S113-S122. PMID 32134478 DOI: 10.1093/Infdis/Jiz447 |
0.339 |
|
| 2020 |
Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, Donnell GO, Galli JD, Swoyer R, Touch S, Wen Z, Antonello J, Zhang L, Flynn JA, Cox KS, et al. Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. Npj Vaccines. 5: 16. PMID 32128257 DOI: 10.1038/s41541-020-0163-z |
0.301 |
|
| 2019 |
Tabata T, Petitt M, Fang-Hoover J, Freed DC, Li F, An Z, Wang D, Fu TM, Pereira L. Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas. Vaccines. 7. PMID 31569508 DOI: 10.3390/Vaccines7040135 |
0.471 |
|
| 2019 |
Adler SP, Lewis N, Conlon A, Christiansen MP, Al-Ibrahim M, Rupp R, Fu TM, Bautista O, Tang H, Wang D, Fisher A, Culp T, Das R, Beck K, Tamms G, et al. Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects. The Journal of Infectious Diseases. 220: 411-419. PMID 31535143 DOI: 10.1093/Infdis/Jiz141 |
0.35 |
|
| 2019 |
Tang A, Chen Z, Cox KS, Su HP, Callahan C, Fridman A, Zhang L, Patel SB, Cejas PJ, Swoyer R, Touch S, Citron MP, Govindarajan D, Luo B, Eddins M, ... ... Wang D, et al. A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. Nature Communications. 10: 4153. PMID 31515478 DOI: 10.1038/S41467-019-12137-1 |
0.405 |
|
| 2019 |
Liu Y, Freed DC, Li L, Tang A, Li F, Murray EM, Adler SP, McVoy MA, Rupp RE, Barrett D, Ye X, Zhang N, Beck K, Culp T, Das R, ... ... Wang D, et al. A Replication Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection. Journal of Virology. PMID 31511385 DOI: 10.1128/Jvi.00747-19 |
0.421 |
|
| 2019 |
Ye X, Gui X, Freed DC, Ku Z, Li L, Chen Y, Xiong W, Fan X, Su H, He X, Rustandi RR, Loughney JW, Ma N, Espeseth AS, Liu J, ... ... Wang D, et al. Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection. Plos Pathogens. 15: e1007914. PMID 31356650 DOI: 10.1371/Journal.Ppat.1007914 |
0.42 |
|
| 2018 |
Vora K, Chen Z, Su H, Tang A, Cox K, Callahan C, Zhang L, Patel S, Nahas D, Citron M, Cejas P, Swoyer R, Luo B, Eddins M, Reid J, ... ... Wang D, et al. 1644. A Potent Broadly Neutralizing Antibody Isolated From Human Memory B-cells Binding to Conserved Site IV on the RSV F Protein Open Forum Infectious Diseases. 5: S47-S48. DOI: 10.1093/Ofid/Ofy209.114 |
0.336 |
|
| 2017 |
Li F, Freed DC, Tang A, Rustandi RR, Troutman MC, Espeseth AS, Zhang N, An Z, McVoy M, Zhu H, Ha S, Wang D, Adler SP, Fu TM. Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination. Npj Vaccines. 2: 36. PMID 29263890 DOI: 10.1038/s41541-017-0038-0 |
0.353 |
|
| 2017 |
Xia L, Tang A, Meng W, Freed DC, He L, Wang D, Li F, Li L, Xiong W, Gui X, Schultz RD, Chen H, He X, Swoyer R, Ha S, et al. Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection. Oncotarget. 8: 73654-73669. PMID 29088734 DOI: 10.18632/Oncotarget.18359 |
0.475 |
|
| 2017 |
Meng W, Tang A, Ye X, Gui X, Li L, Fan X, Schultz RD, Freed DC, Ha S, Wang D, Zhang N, Fu TM, An Z. Targeting Human Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-gB Bispecific Antibody. Antimicrobial Agents and Chemotherapy. PMID 29038280 DOI: 10.1128/Aac.01719-17 |
0.423 |
|
| 2017 |
Phan SI, Adam CM, Chen Z, Citron M, Liang X, Espeseth AS, Wang D, He B. The genetic stability of PIV5-vectored RSV vaccine candidates after in vitro and in vivo passage. Journal of Virology. PMID 28747497 DOI: 10.1128/Jvi.00559-17 |
0.396 |
|
| 2017 |
Phan SI, Zengel JR, Wei H, Li Z, Wang D, He B. Parainfluenza virus 5 (PIV5) expressing wild-type or pre-fusion respiratory syncytial virus (RSV) fusion protein protect mice and cotton rats from RSV challenge. Journal of Virology. PMID 28747496 DOI: 10.1128/Jvi.00560-17 |
0.409 |
|
| 2017 |
Xia L, Tang A, Meng W, Freed DC, He L, Wang D, Li F, Li L, Xiong W, Gui X, Schultz RD, Chen H, He X, Swoyer R, Ha S, et al. Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection. Oncotarget. PMID 28621685 DOI: 10.18632/oncotarget.18359 |
0.388 |
|
| 2017 |
Tang A, Freed DC, Li F, Meschino S, Prokop M, Bett A, Casimiro D, Wang D, Fu TM. Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates. Human Vaccines & Immunotherapeutics. 1-9. PMID 28494195 DOI: 10.1080/21645515.2017.1308988 |
0.461 |
|
| 2017 |
Cui X, Freed DC, Wang D, Qiu P, Li F, Fu TM, Kauvar LM, McVoy MA. Impact of antibodies and strain polymorphisms on cytomegalovirus entry and spread in fibroblasts and epithelial cells. Journal of Virology. PMID 28381568 DOI: 10.1128/Jvi.01650-16 |
0.418 |
|
| 2017 |
Wang D, Phan S, DiStefano DJ, Citron MP, Callahan CL, Indrawati L, Dubey SA, Heidecker GJ, Govindarajan D, Liang X, He B, Espeseth AS. A Single Dose Recombinant PIV5 Expressing Respiratory Syncytial Virus F and G Proteins Protected Cotton Rats and African Green Monkeys from RSV Challenge. Journal of Virology. PMID 28298602 DOI: 10.1128/Jvi.00066-17 |
0.409 |
|
| 2017 |
Ha S, Li F, Troutman MC, Freed DC, Tang A, Loughney JW, Wang D, Wang IM, Vlasak J, Nickle DC, Rustandi RR, Hamm M, DePhillips PA, Zhang N, McLellan JS, et al. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targets Viral gH/gL/pUL128-131 Pentameric Complex. Journal of Virology. PMID 28077654 DOI: 10.1128/Jvi.02033-16 |
0.455 |
|
| 2016 |
Wang D, Freed DC, He X, Li F, Tang A, Cox KS, Dubey SA, Cole S, Medi MB, Liu Y, Xu J, Zhang ZQ, Finnefrock AC, Song L, Espeseth AS, et al. A replication-defective human cytomegalovirus vaccine for prevention of congenital infection. Science Translational Medicine. 8: 362ra145. PMID 27797961 DOI: 10.1126/Scitranslmed.Aaf9387 |
0.478 |
|
| 2016 |
Finnefrock AC, Freed DC, Tang A, Li F, He X, Wu C, Nahas D, Wang D, Fu TM. Preclinical Evaluations of Peptide-Conjugate Vaccines Targeting the Antigenic Domain-2 of Glycoprotein B of Human Cytomegalovirus. Human Vaccines & Immunotherapeutics. 0. PMID 26986197 DOI: 10.1080/21645515.2016.1164376 |
0.364 |
|
| 2015 |
Loughney JW, Rustandi RR, Wang D, Troutman MC, Dick LW, Li G, Liu Z, Li F, Freed DC, Price CE, Hoang VM, Culp TD, DePhillips PA, Fu TM, Ha S. Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes. The Journal of Biological Chemistry. 290: 15985-95. PMID 25947373 DOI: 10.1074/Jbc.M115.652230 |
0.416 |
|
| 2014 |
Fu TM, An Z, Wang D. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease. Vaccine. 32: 2525-33. PMID 24681264 DOI: 10.1016/J.Vaccine.2014.03.057 |
0.431 |
|
| 2014 |
Wang D, Fu TM. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Current Opinion in Virology. 6: 13-23. PMID 24632198 DOI: 10.1016/J.Coviro.2014.02.004 |
0.419 |
|
| 2013 |
Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC, Durr E, Espeseth AS, Casimiro DR, Zhang N, Shiver JW, Wang D, et al. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proceedings of the National Academy of Sciences of the United States of America. 110: E4997-5005. PMID 24297878 DOI: 10.1073/Pnas.1316517110 |
0.461 |
|
| 2012 |
Fu TM, Wang D, Freed DC, Tang A, Li F, He X, Cole S, Dubey S, Finnefrock AC, ter Meulen J, Shiver JW, Casimiro DR. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus Vaccine. 30: 7469-7474. PMID 23107592 DOI: 10.1016/J.Vaccine.2012.10.053 |
0.464 |
|
| 2011 |
Wang D, Li F, Freed DC, Finnefrock AC, Tang A, Grimes SN, Casimiro DR, Fu TM. Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection. Vaccine. 29: 9075-80. PMID 21945962 DOI: 10.1016/J.Vaccine.2011.09.056 |
0.467 |
|
| 2011 |
Tang A, Li F, Freed DC, Finnefrock AC, Casimiro DR, Wang D, Fu TM. A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines. Vaccine. 29: 8350-6. PMID 21888937 DOI: 10.1016/J.Vaccine.2011.08.086 |
0.432 |
|
| 2009 |
Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology. 390: 330-7. PMID 19524994 DOI: 10.1016/J.Virol.2009.05.013 |
0.328 |
|
| 2007 |
Wang D, Yu QC, Schröer J, Murphy E, Shenk T. Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 20037-42. PMID 18077432 DOI: 10.1073/Pnas.0709704104 |
0.435 |
|
| 2005 |
Wang D, Shenk T. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proceedings of the National Academy of Sciences of the United States of America. 102: 18153-8. PMID 16319222 DOI: 10.1073/Pnas.0509201102 |
0.444 |
|
| 2005 |
Wang D, Shenk T. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. Journal of Virology. 79: 10330-8. PMID 16051825 DOI: 10.1128/Jvi.79.16.10330-10338.2005 |
0.424 |
|
| 2004 |
Wang D, Bresnahan W, Shenk T. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 16642-7. PMID 15536129 DOI: 10.1073/Pnas.0407233101 |
0.396 |
|
| 2004 |
Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. Journal of Virology. 78: 10960-6. PMID 15452216 DOI: 10.1128/JVI.78.20.10960-10966.2004 |
0.354 |
|
| 2002 |
Vihinen-Ranta M, Wang D, Weichert WS, Parrish CR. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. Journal of Virology. 76: 1884-91. PMID 11799183 DOI: 10.1128/Jvi.76.4.1884-1891.2002 |
0.59 |
|
| 2001 |
Parker JS, Murphy WJ, Wang D, O'Brien SJ, Parrish CR. Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. Journal of Virology. 75: 3896-902. PMID 11264378 DOI: 10.1128/Jvi.75.8.3896-3902.2001 |
0.57 |
|
| 1999 |
Wang D, Parrish CR. A heterogeneous nuclear ribonucleoprotein A/B-related protein binds to single-stranded DNA near the 5' end or within the genome of feline parvovirus and can modify virus replication. Journal of Virology. 73: 7761-8. PMID 10438866 DOI: 10.1128/Jvi.73.9.7761-7768.1999 |
0.565 |
|
| 1998 |
Wang D, Yuan W, Davis I, Parrish CR. Nonstructural protein-2 and the replication of canine parvovirus. Virology. 240: 273-81. PMID 9454701 DOI: 10.1006/Viro.1997.8946 |
0.574 |
|
| Show low-probability matches. |